* Nephros Inc NEPH.OQ NEPH.O is expected to show a rise
in
quarterly revenue when it reports results on May 9 for the
period ending January 1 0001
* The South Orange New Jersey-based company is expected to
report
a 1.0% increase in revenue to $3.734 million from $3.7 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Nephros Inc is for a
loss of 4
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Nephros Inc
is
$4.75, above its last closing price of $2.20.
This summary was machine generated May 8 at 01:30 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)